Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

440 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer

NCT00376623

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1216.9.49002 Boehringer Ingelheim Investigational Site Freiburg im Breisgau, Germany
  • 1216.9.49007 Boehringer Ingelheim Investigational Site Gauting, Germany
  • 1216.9.49008 Boehringer Ingelheim Investigational Site Großhansdorf, Germany
  • 1216.9.49001 Boehringer Ingelheim Investigational Site Heidelberg, Germany
View Trial Details
Completed

A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy

NCT03270176

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Cross Cancer Center Dept Medicine Edmonton, Alberta, Canada
  • British Columbia Cancer Agency Vancouver, British Columbia, Canada
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • The Ottawa Hospital Cancer Centre (TOHCC) Ottawa, Ontario, Canada
View Trial Details
Completed

Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib

NCT00522145

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Ronald Yanagihara Gilroy, California, United States
  • University of California Davis Cancer Center Sacramento, California, United States
  • Oncology Division and General Clincial Research, Stanford University Medical Center Stanford, California, United States
  • Cancer Care Center, Inc. P.C. New Albany, Indiana, United States
View Trial Details
Completed

VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer

NCT03268057

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +10 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • University of California Los Angeles (UCLA) Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings

NCT02440854

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University General Hospital of Evros Alexandroupoli, Greece
  • Chest Hospital of Athens "Sotiria" Athens, Greece
  • "Attikon" University General Hospital of Attica Haidari, Greece
  • University General Hospital of Heraklion Heraklion, Greece
View Trial Details
Completed

Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer

NCT02810457

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site 7814 - Compassionate Care Research Group Fountain Valley, California, United States
  • Research Site 7811 - Innovative Clinical Research Institute Whittier, California, United States
  • Research Site 7803 - 21st Century Oncology Jacksonville, Florida, United States
  • Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd. Joliet, Illinois, United States
View all 147 locations
View Trial Details

Related conditions